KSHV miRNAs target STING to evade innate immunity and facilitate KSHV lytic reactivation from latency
- Cell Rep. 2025 Jun 24;44(6):115741. doi: 10.1016/j.celrep.2025.115741.
- 1. Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL, USA.
- 2. Department of Microbiology & Cell Science, University of Florida, Gainesville, FL, USA.
- 3. Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA.
- 4. Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA; UF Health Cancer Center, Gainesville, FL, USA. Electronic address: [email protected].
Kaposi sarcoma-associated herpesvirus (KSHV) employs various strategies to evade host immune surveillance and maintain lifelong latency. The Cyclic GMP-AMP Synthase (cGAS)/stimulator of interferon genes (STING) DNA sensing pathway is a key innate immunity pathway that detects viral DNA and restricts KSHV lytic replication upon reactivation from latency. Here, we identify three KSHV MicroRNAs (miRNAs), miR-K12-6-3p, miR-K12-7-3p, and miR-K12-11-3p, that directly bind to STING1 mRNA to repress its translation and inhibit downstream immune signaling. Exogenous delivery of these KSHV miRNAs led to decreased STING expression and attenuated cGAS/STING signaling in response to STING agonist stimulation. Conversely, genetic deletion of these KSHV miRNAs rescued STING and interferon-stimulated gene expression in latent KSHV cell lines, delaying KSHV lytic reactivation and reducing KSHV lytic gene expression. These findings shed light on the immune evasion strategy of KSHV miRNA-mediated STING repression, representing the discovery of viral miRNAs that target STING.
-
Cat. No.Product NameCategory/Application